in line with the vascular and neurogenic theories of migraine, all triptans produce selective carotid vasoconstriction (via 5-ht1b receptors) and presynaptic inhibition of the trigeminovascular inflammatory responses implicated in migraine (via 5-ht1d/5-ht1f receptors).